These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8935990)

  • 21. Bruton's tyrosine kinase is present in normal platelets and its absence identifies patients with X-linked agammaglobulinaemia and carrier females.
    Futatani T; Watanabe C; Baba Y; Tsukada S; Ochs HD
    Br J Haematol; 2001 Jul; 114(1):141-9. PubMed ID: 11472359
    [TBL] [Abstract][Full Text] [Related]  

  • 22. xid affects events leading to B cell cycle entry.
    Brorson K; Brunswick M; Ezhevsky S; Wei DG; Berg R; Scott D; Stein KE
    J Immunol; 1997 Jul; 159(1):135-43. PubMed ID: 9200448
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functions of Bruton's tyrosine kinase in mast and B cells.
    Kawakami Y; Kitaura J; Hata D; Yao L; Kawakami T
    J Leukoc Biol; 1999 Mar; 65(3):286-90. PubMed ID: 10080529
    [TBL] [Abstract][Full Text] [Related]  

  • 24. xid mice reveal the interplay of homeostasis and Bruton's tyrosine kinase-mediated selection at multiple stages of B cell development.
    Cancro MP; Sah AP; Levy SL; Allman DM; Schmidt MR; Woodland RT
    Int Immunol; 2001 Dec; 13(12):1501-14. PubMed ID: 11717191
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Physiology of B cells in mice with X-linked immunodeficiency (xid). III. Disappearance of xid B cells in double bone marrow chimeras.
    Sprent J; Bruce J
    J Exp Med; 1984 Sep; 160(3):711-23. PubMed ID: 6381637
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bruton tyrosine kinase (BTK) in X-linked agammaglobulinemia (XLA).
    Vihinen M; Mattsson PT; Smith CI
    Front Biosci; 2000 Dec; 5():D917-28. PubMed ID: 11102316
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genomic organization of the Btk gene and exon scanning for mutations in patients with X-linked agammaglobulinemia.
    Hagemann TL; Chen Y; Rosen FS; Kwan SP
    Hum Mol Genet; 1994 Oct; 3(10):1743-9. PubMed ID: 7880320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genomic organization and structure of Bruton agammaglobulinemia tyrosine kinase: localization of mutations associated with varied clinical presentations and course in X chromosome-linked agammaglobulinemia.
    Ohta Y; Haire RN; Litman RT; Fu SM; Nelson RP; Kratz J; Kornfeld SJ; de la Morena M; Good RA; Litman GW
    Proc Natl Acad Sci U S A; 1994 Sep; 91(19):9062-6. PubMed ID: 8090769
    [TBL] [Abstract][Full Text] [Related]  

  • 29. B-cell-specific demethylation of BTK, the defective gene in X-linked agammaglobulinemia.
    Parolini O; Rohrer J; Shapiro LH; Conley ME
    Immunogenetics; 1995; 42(2):129-35. PubMed ID: 7541776
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IL-9-induced expansion of B-1b cells restores numbers but not function of B-1 lymphocytes in xid mice.
    Knoops L; Louahed J; Renauld JC
    J Immunol; 2004 May; 172(10):6101-6. PubMed ID: 15128795
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new RFLP marker, SP282, at the btk locus for genetic analysis in X-linked agammaglobulinaemia families.
    Kwan SP; Walker AP; Hagemann T; Gupta S; Vayuvegula B; Ochs HD
    Prenat Diagn; 1994 Jun; 14(6):493-6. PubMed ID: 7937587
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutation screening of the BTK gene in 56 families with X-linked agammaglobulinemia (XLA): 47 unique mutations without correlation to clinical course.
    Holinski-Feder E; Weiss M; Brandau O; Jedele KB; Nore B; Bäckesjö CM; Vihinen M; Hubbard SR; Belohradsky BH; Smith CI; Meindl A
    Pediatrics; 1998 Feb; 101(2):276-84. PubMed ID: 9445504
    [TBL] [Abstract][Full Text] [Related]  

  • 33. X linked agammaglobulinaemia with a 'leaky' phenotype.
    Jones A; Bradley L; Alterman L; Tarlow M; Thompson R; Kinnon C; Morgan G
    Arch Dis Child; 1996 Jun; 74(6):548-9. PubMed ID: 8758136
    [TBL] [Abstract][Full Text] [Related]  

  • 34. X-linked agammaglobulinemia and Bruton's tyrosine kinase.
    Tsukada S; Witte ON
    Adv Exp Med Biol; 1994; 365():233-8. PubMed ID: 7887309
    [No Abstract]   [Full Text] [Related]  

  • 35. SSCP at the BTK locus.
    Vorechovský I
    Hum Mol Genet; 1994 Jun; 3(6):1031. PubMed ID: 7951224
    [No Abstract]   [Full Text] [Related]  

  • 36. X chromosome inactivation analysis to distinguish sporadic cases of X-linked agammaglobulinaemia from common variable immunodeficiency.
    Tsuge I; Matsuoka H; Abe T; Kamachi Y; Torii S
    Eur J Pediatr; 1993 Nov; 152(11):900-4. PubMed ID: 8276019
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human NACHT, LRR, and PYD domain-containing protein 3 (NLRP3) inflammasome activity is regulated by and potentially targetable through Bruton tyrosine kinase.
    Liu X; Pichulik T; Wolz OO; Dang TM; Stutz A; Dillen C; Delmiro Garcia M; Kraus H; Dickhöfer S; Daiber E; Münzenmayer L; Wahl S; Rieber N; Kümmerle-Deschner J; Yazdi A; Franz-Wachtel M; Macek B; Radsak M; Vogel S; Schulte B; Walz JS; Hartl D; Latz E; Stilgenbauer S; Grimbacher B; Miller L; Brunner C; Wolz C; Weber ANR
    J Allergy Clin Immunol; 2017 Oct; 140(4):1054-1067.e10. PubMed ID: 28216434
    [TBL] [Abstract][Full Text] [Related]  

  • 38. X-linked agammaglobulinemia--gene cloning and future prospects.
    Kinnon C; Hinshelwood S; Levinsky RJ; Lovering RC
    Immunol Today; 1993 Nov; 14(11):554-8. PubMed ID: 8274198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An essential role for Bruton's [corrected] tyrosine kinase in the regulation of B-cell apoptosis.
    Anderson JS; Teutsch M; Dong Z; Wortis HH
    Proc Natl Acad Sci U S A; 1996 Oct; 93(20):10966-71. PubMed ID: 8855292
    [TBL] [Abstract][Full Text] [Related]  

  • 40. X-linked agammaglobulinemia.
    Timmers E; de Weers M; Alt FW; Hendriks RW; Schuurman RK
    Clin Immunol Immunopathol; 1991 Nov; 61(2 Pt 2):S83-93. PubMed ID: 1934617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.